Related Articles
Study on the infusion‑site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients
Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline‑based regimens
Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant
Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia